Pharmafile Logo

Solving your biggest patient recruitment and retention challenges

- PMLiVE

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to enrollment issues [1,2], and poor recruitment is a common reason for discontinuation [3]. Of those successfully enrolled, around 30% are likely to drop out [4], which increases costs for sponsors and threatens the viability of the trial itself.

Directly supporting patients from prescreening to study endpoint can help minimize delays and safeguard against early termination, but this can be difficult for hard-pressed sites. Join us as we discuss the most common patient support challenges – as described to us by YOU – and how our new Navigator can solve them by giving patients a more personalized clinical trial experience and consistent contact, alleviating the burden on sites, and ensuring a sponsor’s study runs efficiently to help accelerate patient access to life-changing treatments.

We will share our insight into why the ‘human touch’ can elevate your in-study patient engagement to the next level and how this permeates through our Navigator service to benefit patients, sites and sponsors. You will also hear from a sponsor that has benefitted from our expertise: the difficulties they faced, the solutions we implemented and the difference we made. And we will share feedback from clinical trial participants about what they think of our support.

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Accelerating patient recruitment in clinical trials post COVID-19

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...

Diversity in Clinical Trials: A more inclusive approach in patient recruitment

We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient...

Innovative Trials partners with MS Society

UK-based patient recruitment company announces its annual charity partnership in support of multiple sclerosis

FREE Live Webinar – Accelerating Patient recruitment in Clinical Trials post COVID-19 – 8th June 2022

Innovative Trials and Parexel invite you to attend the live webinar

Innovative Trials named a finalist in the Inspiring Hertfordshire Awards

The patient recruitment organisation has been shortlisted in the Inspiring Hertfordshire awards

Innovative Trials suspends services in Russia in response to Ukraine war

Kate Shaw, Founder & CEO of the leading patient recruitment organisation based in Letchworth (UK), on the current Russia-Ukraine situation.

Improving diversity in clinical trial patient recruitment

A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment...

Increasing patient randomisation rate by 200% for a Top 5 global pharma

Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study

Eating Disorders Awareness Week

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders

FREE Live Webinar – Diversity in Clinical Trials – 24th February

Innovative Trials, Pfizer and Parexel invite you to attend the live webinar